Literature DB >> 24557481

Functional paraganglioma.

Gokulakrishnan Balasubramanian1, Vallikantha Nellaiappan.   

Abstract

Paraganglioma are tumours arising from neural crest cells of the sympathetic and parasympathetic paraganglia. Functional paraganglioma presents with symptoms of catecholamine excess that includes hypertension, flushing, diaphoresis, etc. Non-functional paraganglioma are usually found incidentally during imaging studies. Early diagnoses of functional paraganglioma are important because their removal is often curative. We present the case of a young man who presented with hypertensive crisis and severe headache, who was later found to have functional paraganglioma.

Entities:  

Mesh:

Year:  2014        PMID: 24557481      PMCID: PMC3931965          DOI: 10.1136/bcr-2013-203425

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Nifedipine in pheochromocytoma.

Authors:  L Favre; M B Vallotton
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

2.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

3.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

4.  Malignant vagal paraganglioma: report of a case treated with embolization and surgery.

Authors:  Camilla S Carlsen; Christian Godballe; Annelise S Krogdahl; Anette L Edal
Journal:  Auris Nasus Larynx       Date:  2003-12       Impact factor: 1.863

5.  Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.

Authors:  J Bomanji; K E Britton; E Ur; L Hawkins; A B Grossman; G M Besser
Journal:  Nucl Med Commun       Date:  1993-10       Impact factor: 1.690

6.  Malignant head and neck paragangliomas in SDHB mutation carriers.

Authors:  Carsten Christof Boedeker; Hartmut P H Neumann; Wolfgang Maier; Birke Bausch; Jörg Schipper; Gerd Jürgen Ridder
Journal:  Otolaryngol Head Neck Surg       Date:  2007-07       Impact factor: 3.497

Review 7.  The diagnosis and management of malignant phaeochromocytoma and paraganglioma.

Authors:  Alexandra Chrisoulidou; Gregory Kaltsas; Ioannis Ilias; Ashley B Grossman
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

Review 8.  The diagnosis and medical management of advanced neuroendocrine tumors.

Authors:  Gregory A Kaltsas; G Michael Besser; Ashley B Grossman
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

9.  Scintigraphic localization of pheochromocytoma.

Authors:  J C Sisson; M S Frager; T W Valk; M D Gross; D P Swanson; D M Wieland; M C Tobes; W H Beierwaltes; N W Thompson
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

10.  Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.

Authors:  Hui Huang; Jame Abraham; Elizabeth Hung; Steven Averbuch; Maria Merino; Seth M Steinberg; Karel Pacak; Tito Fojo
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.921

View more
  1 in total

1.  An incidental finding of retroperitoneal paraganglioma during the coronavirus disease 2019 pandemic: a case report.

Authors:  K Ben Hamida; M Slimane; A Mlouka; N Boujelbene; S Essghaier; K Rahal
Journal:  J Med Case Rep       Date:  2022-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.